​

PMV Pharmaceuticals (PMVP) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

PMVP Stock Forecast

PMV Pharmaceuticals (PMVP) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 500.00% increase from the last price of $1.00.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $1

PMVP Stock Rating

PMV Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

PMVP Price Target Upside V Benchmarks

TypeNameUpside
StockPMV Pharmaceuticals500.00%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$6.00
Last Closing Price$1.00$1.00$1.00
Upside/Downside--500.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2515---6
Mar, 25-5---5
Feb, 2515---6
Jan, 2515---6
Dec, 24151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 08, 2024Jeff JonesOppenheimer$6.00$1.75242.86%500.00%
Apr 11, 2024Kambiz YazdiJefferies$5.00$1.58216.46%400.00%
Nov 17, 2022H.C. Wainwright$36.00$10.29249.85%3500.00%
Jun 09, 2022Oppenheimer$33.00$10.24222.27%3200.00%
May 24, 2022Goldman Sachs$25.00$14.0977.43%2400.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 08, 2024OppenheimerOutperformOutperformupgrade
May 13, 2024Craig-HallumBuyinitialise
Apr 11, 2024JefferiesBuyinitialise
Jun 09, 2022OppenheimerOutperformOutperformhold
May 24, 2022Goldman SachsBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.77$-1.44$-1.14----
Avg Forecast$-2.06$-1.47$-1.25$-1.57$-1.63$-1.50$-0.46
High Forecast$-2.06$-1.42$-1.21$-1.12$-1.18$-1.11$-0.46
Low Forecast$-2.06$-1.51$-1.28$-1.80$-1.91$-2.01$-0.46
Surprise %-62.62%-2.04%-8.80%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$30.00K---$2.92M$64.13M$124.73M
High Forecast$30.00K---$2.92M$64.13M$124.73M
Low Forecast$30.00K---$2.92M$64.13M$124.73M
Surprise %-------

Net Income Forecast

$-100M $-84M $-68M $-52M $-36M $-20M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.44M$-68.96M$-58.71M----
Avg Forecast$-98.79M$-68.96M$-59.86M$-84.40M$-74.13M$-82.06M$-22.09M
High Forecast$-98.79M$-68.15M$-58.16M$-53.81M$-56.66M$-53.16M$-22.09M
Low Forecast$-98.79M$-72.35M$-61.55M$-86.29M$-91.61M$-96.55M$-22.09M
Surprise %-65.14%--1.92%----

PMVP Forecast FAQ

Is PMV Pharmaceuticals stock a buy?

PMV Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that PMV Pharmaceuticals is a favorable investment for most analysts.

What is PMV Pharmaceuticals's price target?

PMV Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 500.00% change from the previous closing price of $1.

How does PMV Pharmaceuticals stock forecast compare to its benchmarks?

PMV Pharmaceuticals's stock forecast shows a 500.00% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for PMV Pharmaceuticals over the past three months?

  • April 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is PMV Pharmaceuticals’s EPS forecast?

PMV Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.57, marking a 37.72% increase from the reported $-1.14 in 2024. Estimates for the following years are $-1.63 in 2026, $-1.5 in 2027, and $-0.46 in 2028.

What is PMV Pharmaceuticals’s revenue forecast?

PMV Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $2.92M, followed by $64.13M for 2027, and $124.73M for 2028.

What is PMV Pharmaceuticals’s net income forecast?

PMV Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-84.404M, representing an 43.77% increase from the reported $-58.709M in 2024. Projections indicate $-74.134M in 2026, $-82.062M in 2027, and $-22.087M in 2028.